Santa Monica, United States
MAX BioPharma, Inc. is a California-based biotechnology company founded in 2010. The company focuses on developing innovative small molecule lipids known as oxysterols, with a goal of pioneering new treatments for severe and life-threatening illnesses. These compounds, which are part of the sterol family, show promising potential as therapeutic drugs for combatting cancer cell proliferation, preventing metastasis, and most notably, stimulating bone growth. Through their research and developments, MAX BioPharma aims to revolutionize the field of biopharma, biotechnology, and healthcare.
The company's slogan, "Pioneering new treatments for severe and life-threatening illnesses through innovative small molecule lipids that stimulate bone growth and combat cancer," aptly summarizes their mission and vision in the medical field.
MAX BioPharma, Inc. operates within the biopharma, biotechnology, and healthcare industries, with its headquarters based in the United States.
As of now, there is no publicly available information about their last investment or the investors involved in their most recent funding round.
Cidara Therapeutics
